Thomas Martin Kuendig
CIK: 0002088590
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XBIT
XBiotech Inc.
Director
Discretionary Trading P&L
Holdings
About Kuendig Thomas Martin
Kuendig Thomas Martin (SEC CIK 0002088590) files insider reports with the SEC as Director of XBiotech Inc. (XBIT).
Signal8 holds 2 ownership filings by Kuendig Thomas Martin (1 Form 3, 1 Form 4), filed between Sep 30, 2025 and Nov 12, 2025. Those filings report 1 transaction, the latest on Oct 1, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Kuendig Thomas Martin's filings is in RUESCHLIKON, V8.
Recent filings by Kuendig Thomas Martin
- Oct 1, 2025: Grant or award of XBIT derivative securities (Form 4, code A).
Other insiders filing for XBiotech Inc. (XBIT)
- Simard Jan-Paul, Co-Chief Executive Officer
- SIMARD JOHN, Director
- Rademaker Craig Evan, Director
- Soffer David Spencer, Director
- Troy Tevi David, Director